Stockreport

Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF Single ascending dose data show IMC-I109V has manageable safety profile and antiviral activity IMC-I109V is a bispecific T cell receptor targeting a peptide derived fro [Read more]